Schedule 13D ownership disclosure

Dermata Therapeutics, Inc.

Common Stock, Par Value $0.0001 Per Share. · CUSIP: 249845108

Event date: 2025-03-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • PROEHL GERALD TReported CIK 0001279191

    Shares: 804,098.00 · Class: 7.8%

  • Proehl Investment Ventures LLCReported CIK 0001877913

    Shares: 799,624.00 · Class: 7.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-002621
Form type
SCHEDULE 13D/A
Filer
Dermata Therapeutics, Inc.
CIK
CIK 1853816
Filed
Apr 03, 2025
Reporting period
Mar 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub